Business

Steriwave proven effective against XDR bacteria

Steriwave proven effective against XDR bacteria.

articleOndine Biomedical, Inc.September 14, 20235/company/ondine-biomedical-inc/news/steriwave-proven-effective-against-xdr-bacteria
Steriwave proven effective against XDR bacteria

About this update from Ondine Biomedical, Inc.

[{"type":"text","content":"\n\n14 September 2023\nONDINE BIOMEDICAL INC. \n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\") \nSteriwave proven highly effective against XDR bacteria\nOndine to present research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva\nCanadian life sciences company Ondine Biomedical Inc. (LON: OBI) is presenting new research at the 2023 International Consortium on Prevention & Infection Control (ICPIC) in Geneva, demonstrating high efficacy of its patented photodisinfection technology against extensively drug-resistant (XDR) bacteria. Ondine is the global leader in developing photodisinfection-based therapies for the prevention of healthcare-associated infections.\nThe study demonstrates that Ondine's Steriwave™ photodisinfection technology is highly effective (>99.99% kills in 20 seconds) against both moderately drug-resistant (MDR) and extensively drug-resistant (XDR) pathogens. Gram-negative bacteria, such as Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Klebsiella pneumoniae cause many serious healthcare-associated infections.  The research underlines the potential for Steriwave to become a rapid, broad-spectrum, bactericidal alternative to antibiotics.\nAntimicrobial resistance (AMR) poses an urgent global public health threat resulting in 1.27 million annual deaths worldwide, and is predicted to become one of the largest threats to human health in the coming years.[i] The emergence and worldwide spread of extensively drug-resistant (XDR) microbes is highly concerning, as infections caused by these pathogens are virtually untreatable because they are proving resistant to almost all approved antimicrobial agents.[ii],[iii]\nDr. Nicolas Loebel, Ondine's CTO and President, commented: \"Overuse of antibiotics over decades has caused adaptation in many microbes, and we now see multidrug resistance (MDR) evolving into extensive drug resistance (XDR) in bacteria, rendering even the most powerful combination of drugs ineffective. We believe photodisinfection can play a significant role in cost-effectively combatting these drug-resistant pathogens and reducing global reliance on antibiotics.  We know of no other antimicrobial that can match the performance, safety, and cost benefits of photodisinfection.\"\nOndine's Steriwave syste...

More updates from Ondine Biomedical, Inc.